Inhibition/NN
of/IN
lipopolysaccharide-induced/JJ
monocyte/NN
interleukin-1/NN
receptor/NN
antagonist/NN
synthesis/NN
by/IN
cortisol/NN
:/:
involvement/NN
of/IN
the/DT
mineralocorticoid/NN
receptor/NN
./.

Glucocorticoids/NNS
,/,
as/IN
a/DT
part/NN
of/IN
their/PRP$
physiological/JJ
role/NN
in/IN
the/DT
control/NN
of/IN
inflammatory/JJ
and/CC
immune/JJ
processes/NNS
,/,
suppress/VBP
the/DT
expression/NN
of/IN
interleukin-1/NN
(/(
IL-1/NN
)/)
and/CC
other/JJ
cytokines/NNS
./.
=====
Human/JJ
monocyte/NN
IL-1/NN
receptor/NN
antagonist/NN
(/(
IL-1ra/NN
)/)
messenger/NN
ribonucleic/NN
acid/NN
(/(
mRNA/NN
)/)
expression/NN
and/CC
protein/NN
secretion/NN
are/VBP
inhibited/VBN
by/IN
dexamethasone/NN
./.
=====
We/PRP
have/VBP
now/RB
further/RB
studied/VBN
the/DT
regulation/NN
of/IN
IL-1ra/NN
by/IN
the/DT
major/JJ
physiological/JJ
human/JJ
glucocorticoid/NN
,/,
cortisol/NN
./.
=====
We/PRP
found/VBD
that/IN
cortisol/NN
incubation/NN
induced/VBD
a/DT
decrease/NN
in/IN
IL-1ra/NN
mRNA/NN
expression/NN
and/CC
a/DT
significant/JJ
inhibition/NN
of/IN
IL-1ra/NN
protein/NN
secretion/NN
in/IN
cell/NN
cultures/NNS
of/IN
human/JJ
peripheral/JJ
monocytes/NNS
stimulated/VBN
with/IN
the/DT
bacterial/JJ
endotoxin/NN
lipopolysaccharide/NN
(/(
LPS/NN
)/)
./.
=====
Oral/JJ
administration/NN
of/IN
276/CD
mumol/NN
cortisol/NN
to/TO
normal/JJ
subjects/NNS
also/RB
decreased/VBD
LPS-induced/JJ
IL-1ra/NN
synthesis/NN
in/IN
cultured/VBN
monocytes/NNS
./.
=====
By/IN
coincubating/VBG
the/DT
monocytes/NNS
with/IN
either/CC
the/DT
mineralocorticoid/NN
antagonist/NN
spironolactone/NN
or/CC
the/DT
glucocorticoid/NN
receptor/NN
antagonist/NN
RU/NN
38486/CD
,/,
the/DT
in/FW
vitro/FW
cortisol-induced/JJ
inhibition/NN
of/IN
LPS-stimulated/JJ
IL-1ra/NN
secretion/NN
was/VBD
partially/RB
reversed/VBN
./.
=====
The/DT
mineralocorticoid/NN
aldosterone/NN
exerted/VBD
a/DT
significant/JJ
decrease/NN
in/IN
LPS-induced/JJ
monocyte/NN
IL-1ra/NN
secretion/NN
in/FW
vitro/FW
,/,
which/WDT
was/VBD
blocked/VBN
by/IN
coincubation/NN
with/IN
spironolactone/NN
./.
=====
In/IN
addition/NN
,/,
the/DT
expression/NN
of/IN
mineralocorticoid/NN
receptor/NN
mRNA/NN
in/IN
human/JJ
monocytes/NNS
was/VBD
observed/VBN
by/IN
PCR/NN
of/IN
reversed/VBN
transcribed/VBN
RNA/NN
./.
=====
Our/PRP$
results/NNS
further/RB
indicate/VBP
that/IN
corticosteroids/NNS
physiologically/RB
control/VBP
the/DT
IL-1/IL-1ra/JJ|NN
system/NN
during/IN
inflammatory/JJ
or/CC
immune/JJ
processes/NNS
./.
=====
Moreover/RB
,/,
we/PRP
provide/VBP
evidence/NN
that/IN
,/,
in/IN
addition/NN
to/TO
a/DT
glucocorticoid/NN
receptor-mediated/JJ
effect/NN
,/,
the/DT
mineralocorticoid/NN
receptor/NN
is/VBZ
involved/VBN
in/IN
the/DT
inhibition/NN
of/IN
monocyte/NN
IL-1ra/NN
secretion/NN
by/IN
cortisol/NN
./.